The report
“Dialysis Market [(Hemodialysis - Machine, Dialyzer,
Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter,
Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis
Center, Home Dialysis)] – Global Forecast to 2018” by MarketsandMarkets is now available at RnRMarketResearch.com.
Contact sales@rnrmarketresearch.com with report name in subject line
and your contact details to purchase this report or get your questions
answered.
The global
dialysis market is broadly categorized into two segments, namely, hemodialysis
(products & services) and peritoneal dialysis (products & services).
The hemodialysis segment accounts for the larger share of the global dialysis
market, while the peritoneal dialysis segment is expected to grow at a higher
CAGR in the forecast period. The hemodialysis (HD) products and services market
includes machines, consumables, and services. The peritoneal dialysis (PD)
products and services market includes concentrates/dialysates, cyclers,
catheters, transfer sets, accessories, and PD services.
Moreover,
the global dialysis market has also been classified on the basis of end users
into in-center dialysis and home dialysis. The hemodialysis market is further
segmented into center use HD and home HD. The peritoneal dialysis market is
segmented into continuous cycling peritoneal dialysis (CCPD), continuous
ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy.
The in-center dialysis end users market includes hospitals and independent
dialysis centers; whereas, the home dialysis end users market includes
peritoneal dialysis end users and home hemodialysis end users. Based on
geography, the market is divided into North America, Asia-Pacific, Europe, and
Rest of the World (RoW).
Complete report available @ http://www.rnrmarketresearch.com/dialysis-market-hemodialysis-machine-dialyzer-bloodlines-concentrates-services-peritoneal-dialysis-cycler-catheter-dialysate-ccpd-capd-ipd-end-users-hospital-independent-dialys-market-report.html
.
A number of factors such as the growing number of end stage renal
disease patients and increasing prevalence of diabetes and hypertension are
driving the growth of the dialysis market. In addition, factors such as low
preference of patients for kidney transplantation, technological advancements,
increase in private investment and venture funding to support the development
of new products, and substantial government healthcare expenditure on the
treatment of end-stage renal disease are further stimulating the growth of the
dialysis products and services market. However, factors such as low awareness
about kidney diseases and their treatment modalities (primarily in developing
countries), reduction in Medicare reimbursements to dialysis centers, product
recalls, and reuse of hemodialysis consumables (such as dialyzers and
bloodlines) are restraining the growth of the dialysis market.
In 2013, North America holds the largest share in the global dialysis
market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The
Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of
Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period.
Factors such as the increasing number of independent dialysis centers,
government initiatives to develop dialysis facilities, and increasing awareness
about new dialysis treatment modalities are driving the growth of the dialysis
market in the Asia-Pacific region.
Request a
sample copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=129563
.
The major players in the dialysis market include Fresenius Medical Care
AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB
(Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany),
Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical
Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc.
(U.S.).
11 Company
Profiles (Overview, Financials, Products & Services, Strategy, &
Developments)
11.1 Asahi Kasei Medical Co., Ltd.
11.2 B. Braun Melsungen Ag
11.3 Baxter International, Inc.
11.4 Bellco S.R.L.
11.5 Covidien, Plc
11.6 Davita Healthcare Partners, Inc.
11.7 Diaverum Deutschland Gmbh
11.8 Fresenius Medical Care Ag & Co. Kgaa
11.9 Gambro Ab
11.10 Kawasumi Laboratories, Inc.
11.11 Medical Components, Inc.
11.12 Medionics International, Inc.
11.13 Nikkiso Co. Ltd.
11.14 Nipro Corporation
11.15 Nxstage Medical, Inc.
11.1 Asahi Kasei Medical Co., Ltd.
11.2 B. Braun Melsungen Ag
11.3 Baxter International, Inc.
11.4 Bellco S.R.L.
11.5 Covidien, Plc
11.6 Davita Healthcare Partners, Inc.
11.7 Diaverum Deutschland Gmbh
11.8 Fresenius Medical Care Ag & Co. Kgaa
11.9 Gambro Ab
11.10 Kawasumi Laboratories, Inc.
11.11 Medical Components, Inc.
11.12 Medionics International, Inc.
11.13 Nikkiso Co. Ltd.
11.14 Nipro Corporation
11.15 Nxstage Medical, Inc.
Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=129563
.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.